| Strategy Director (Consultant) - Clinical Development - Evinova | AstraZeneca | Boston, United States | 2026-06-25 |
| Medical Science Liaison - R&I | AstraZeneca | Taiwan | 2026-06-25 |
| Medical Representative_R&I(North) | AstraZeneca | Taiwan | 2026-06-25 |
| Global Development Senior Medical Director, Hematology Oncology | AstraZeneca | Barcelona, Spain | 2026-06-25 |
| Global Development Medical Director, Hematology Oncology | AstraZeneca | Gaithersburg, United States | 2026-06-25 |
| Medical Representative - HCM City | Novo Nordisk | Ho Chi Minh City, Vietnam | 2026-06-25 |
| Medical Scientific Liaison | Novo Nordisk | Bucharest, Romania | 2026-06-25 |
| Associate Director, Medical Education | Novo Nordisk | Ontario, United States | 2026-06-25 |
| Head of Medical & Regulatory | Novo Nordisk | Taipei, Taiwan | 2026-06-25 |
| Clinical Medical Manager | Novo Nordisk | Beijing, China | 2026-06-25 |
| Principal Pharmacovigilance Specialist - Customer engagement activities | Novo Nordisk | Gladsaxe, Denmark | 2026-06-25 |
| Principal Pharmacovigilance Specialist - External partner management | Novo Nordisk | Gladsaxe, Denmark | 2026-06-25 |
| Medical Specialist | Novo Nordisk | Taipei, Taiwan | 2026-06-25 |
| Clinical Pharmacology Scientific Director - Cardiometabolic Diseases, Sรธborg, Denmark | Novo Nordisk | Gladsaxe, Denmark | 2026-06-25 |
| Principal Clinical Pharmacology Specialist - Diabetes, Sรธborg, Denmark | Novo Nordisk | Gladsaxe, Denmark | 2026-06-25 |
| Senior Clinical Pharmacology Specialist - Clinical Pharmacology Cardiometabolic | Novo Nordisk | Gladsaxe, Denmark | 2026-06-25 |
| Medical Liaison -Rare Bleeding Disorders - Ohio Valley - KY, OH, PA, WV | Novo Nordisk | Philadelphia, United States | 2026-06-25 |
| Principal Clinical Pharmacology Specialist - Cardiometabolic, Sรธborg, Denmark | Novo Nordisk | Gladsaxe, Denmark | 2026-06-25 |
| Medical Specialist-่บๅ | Novo Nordisk | Taipei, Taiwan | 2026-06-25 |